Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program

Publication Description
OBJECTIVE: We tested genetic associations with weight loss and weight regain in the Diabetes Prevention Program, a randomized controlled trial of weight loss-inducing interventions (lifestyle and metformin) versus placebo. RESEARCH DESIGN AND METHODS: Sixteen obesity-predisposing single nucleotide polymorphisms (SNPs) were tested for association with short-term (baseline to 6 months) and long-term (baseline to 2 years) weight loss and weight regain (6 months to study end). RESULTS: Irrespective of treatment, the Ala12 allele at PPARG associated with short- and long-term weight loss (-0.63 and -0.93 kg/allele, P

Primary Author
Delahanty,L. M.
Pan,Q.
Jablonski,K. A.
Watson,K. E.
McCaffery,J. M.
Shuldiner,A.
Kahn,S. E.
Knowler,W. C.
Florez,J. C.
Franks,P. W.
Diabetes Prevention Program Research Group

Author Address
Diabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Volume
35

Issue
2

Start Page
363

Other Pages
366

Author Address
Diabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

PMID
22179955

PMCID
PMC3263869



Reference Type
Journal Article

Periodical Full
Diabetes care

Publication Year
2012

Place of Publication
United States

ISSN/ISBN
1935-5548

Document Object Index
10.2337/dc11-1328

Accession Number
dc11-1328v1